Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05665699
PHASE2

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

Sponsor: InventisBio Co., Ltd

View on ClinicalTrials.gov

Summary

D-0120 is being tested in combination with Allopurinol in adult subjects with Gout.

Official title: A Randomized, Open-Label, Multiple-Dose Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2023-04-17

Completion Date

2025-12-30

Last Updated

2025-05-08

Healthy Volunteers

No

Conditions

Interventions

DRUG

D-0120

increasing dose of D-0120

DRUG

Allopurinol

standard dosing

Locations (19)

Study Center

Birmingham, Alabama, United States

Site Center

Plantation, Florida, United States

Study Center

Evergreen Park, Illinois, United States

Study Center

Brownsburg, Indiana, United States

Site Center

Louisville, Kentucky, United States

Study Center

Hickory, North Carolina, United States

Study Center

Rocky Mount, North Carolina, United States

Study Center

Salisbury, North Carolina, United States

Study Center

Wilmington, North Carolina, United States

Study Center

Winston-Salem, North Carolina, United States

Study Center

Scottdale, Pennsylvania, United States

Study Center

Bristol, Tennessee, United States

Site Center

Hendersonville, Tennessee, United States

Study Center

Knoxville, Tennessee, United States

Site Center

Fort Worth, Texas, United States

Site Center

The Woodlands, Texas, United States

Site Center

Richmond, Virginia, United States

Site Center

Bellevue, Washington, United States

Study Center

Morgantown, West Virginia, United States